Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab

Clinical trial NCT00308581 · COMPLETED

Trial details

NCT number: NCT00308581
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2006-04-01
Primary completion: 2008-04-01
Enrollment: 539

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.